Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMFJZN0)

Drug Name

Romosozumab Drug Info

Synonyms

AMG 785

Indication

Disease Entry	ICD 11	Status	REF
Postmenopausal osteoporosis	FB83.11	Approved	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Sclerostin (SOST)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
UX143	DM89NIB	Osteogenesis imperfecta	LD24.K0	Phase 3	[2]
LY2541546	DMTVU2Q	Osteoporosis	FB83.0	Phase 2	[3]
BPS-804	DMDYZRS	Metabolic bone disease	FB8Y	Phase 2	[4]
AMG 167	DMUETI2	Osteoporosis	FB83.0	Phase 1	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2	Clinical pipeline report, company report or official report of Ultragenyx Pharmaceutical
3	Rat-specific decreases in platelet count caused by a humanized monoclonal antibody against sclerostin. Toxicol Sci. 2012 Feb;125(2):586-94.
4	WO patent application no. 2010,1001,79, Self-forming gel system for sustained drug delivery.
5	Osteoporosis - a current view of pharmacological prevention and treatment. Drug Des Devel Ther. 2013; 7: 435-448.